Cutia Therapeutics Limited (2487)
HKEX HKEX Primary Summary
Cutia Therapeutics Limited (2487) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Cutia Therapeutics Limited ever had a stock split?
Cutia Therapeutics Limited Profile
| Biotechnology Industry | Healthcare Sector | Ms. Lele Zhang CEO | HKEX Exchange | KYG2606C1006 ISIN |
| China Country | 304 Employees | - Last Dividend | - Last Split | - IPO Date |
Overview
Cutia Therapeutics is a biopharmaceutical company established in 2019, dedicated to advancing dermatological care and treatments. With its headquarters in Shanghai, China, and additional offices in Beijing, Wuxi, and Hong Kong, the company has positioned itself as a significant player in the arena of dermatology. Cutia Therapeutics is focused on the development of innovative solutions for a range of skin and scalp diseases, leveraging a specialized dermatology platform. The company’s mission is to address the unmet needs within dermatological therapeutic areas, aiming to improve the quality of life for patients suffering from various skin conditions.
Products and Services
Cutia Therapeutics offers a range of products and services tailored to the dermatological sector, focusing on several key therapeutic areas:
- Localized Adipose Accumulation Management Medication: This category includes treatments developed by Cutia Therapeutics aimed at managing conditions related to localized fat deposits. These innovative solutions are designed to address issues such as lipomas and other non-cancerous growths that result from the accumulation of fat cells under the skin, providing patients with effective management options.
- Scalp Diseases and Care: Focusing on a variety of scalp conditions, Cutia Therapeutics develops products intended for the treatment and care of diseases affecting the scalp. This encompasses conditions like psoriasis, dermatitis, and dandruff, offering patients therapies that not only address the symptoms but also the underlying causes of these disorders, promoting scalp health.
- Skin Diseases and Care: With an array of treatments for skin diseases, Cutia Therapeutics is committed to providing care for conditions such as eczema, acne, and rosacea. Their portfolio includes medication that targets both the symptoms and root causes of these diseases, aiming to enhance skin health and patient well-being.
- Topical Anesthesia: This area of focus involves the development of topical anesthetic products. These products are designed to numb the skin surface, providing pain relief for minor surgical procedures, needle insertions, and other dermatological treatments that may cause discomfort. Cutia Therapeutics' topical anesthesia solutions aim to improve patient comfort and procedural outcomes.
